pepmg_

Study summary · research use only

Emerging roles for kisspeptin in metabolism

Study · human · The Journal of physiology · 2022 · DOI 10.1113/JP281712 · PMID 33977536

Plain-language summary

Paraphrased from the published abstract below — not a verdict on whether anything works.

This review article discusses kisspeptin, a neuropeptide hormone, and its reported roles beyond the hypothalamic-pituitary-gonadal axis and reproductive behavior, focusing on emerging evidence for roles in metabolic regulation. The authors describe kisspeptin as potentially acting indirectly via gonadal hormones and/or directly via the kisspeptin receptor in the brain, pancreas, and brown adipose tissue, with kisspeptin receptor knockout studies suggesting sexually dimorphic roles in energy expenditure, food intake, and body weight. The article notes that some in vitro work reports effects on glucose-stimulated insulin secretion, and that acute and chronic studies in rodents, non-human primates, and humans have reported enhancement of glucose-stimulated insulin secretion with pharmacological doses of kisspeptin, while noting further research is needed across diverse human populations.

Abstract

Kisspeptin, a neuropeptide hormone, has been firmly established as a key regulator of the hypothalamic-pituitary-gonadal axis and mammalian reproductive behaviour. In recent years, a growing body of evidence has emerged suggesting a role for kisspeptin in regulating metabolic processes. This data suggest that kisspeptin exerts its metabolic effects indirectly via gonadal hormones and/or directly via the kisspeptin receptor in the brain, pancreas and brown adipose tissue. Kisspeptin receptor knockout studies indicate that kisspeptin may play sexually dimorphic roles in the physiological regulation of energy expenditure, food intake and body weight. Some, but not all, in vitro work demonstrates positive effects on glucose-stimulated insulin secretion, which is more marked at higher kisspeptin concentrations. Acute and chronic in vivo rodent, non-human primate and human studies reveal enhancement of glucose-stimulated insulin secretion in response to pharmacological doses of kisspeptin. Although significant progress has been made in elucidating the metabolic effects of kisspeptin, further mechanistic work and translational studies are required to address unanswered questions and establish the metabolic effects of kisspeptin in diverse human populations (including women, people with obesity and people with diabetes).

Read the full study on PubMed ↗ Open-access full text ↗

pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.